Global Prostacyclin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Prostacyclin market size was valued at USD 2435.5 million in 2023 and is forecast to a readjusted size of USD 3858.7 million by 2030 with a CAGR of 6.8% during review period.

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.

United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.

North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.

In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.

The Global Info Research report includes an overview of the development of the Prostacyclin industry chain, the market status of For Injection (Epoprostenol Sodium, Treprostinil), For Oral (Epoprostenol Sodium, Treprostinil), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prostacyclin.

Regionally, the report analyzes the Prostacyclin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prostacyclin market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Prostacyclin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prostacyclin industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Unit), revenue generated, and market share of different by Type (e.g., Epoprostenol Sodium, Treprostinil).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prostacyclin market.

Regional Analysis: The report involves examining the Prostacyclin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prostacyclin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Prostacyclin:
Company Analysis: Report covers individual Prostacyclin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prostacyclin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (For Injection, For Oral).

Technology Analysis: Report covers specific technologies relevant to Prostacyclin. It assesses the current state, advancements, and potential future developments in Prostacyclin areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prostacyclin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Prostacyclin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Epoprostenol Sodium
    Treprostinil
    Iloprost
    Beraprost Sodium

Market segment by Application
    For Injection
    For Oral
    For Inhalation

Major players covered
    United Therapeutics
    Actelion (J & J)
    GSK
    Teva
    Toray
    Tide Pharma
    Bayer AG

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostacyclin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prostacyclin, with price, sales, revenue and global market share of Prostacyclin from 2019 to 2024.
Chapter 3, the Prostacyclin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostacyclin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Prostacyclin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prostacyclin.
Chapter 14 and 15, to describe Prostacyclin sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Prostacyclin
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Prostacyclin Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Epoprostenol Sodium
        1.3.3 Treprostinil
        1.3.4 Iloprost
        1.3.5 Beraprost Sodium
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Prostacyclin Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 For Injection
        1.4.3 For Oral
        1.4.4 For Inhalation
    1.5 Global Prostacyclin Market Size & Forecast
        1.5.1 Global Prostacyclin Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Prostacyclin Sales Quantity (2019-2030)
        1.5.3 Global Prostacyclin Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 United Therapeutics
        2.1.1 United Therapeutics Details
        2.1.2 United Therapeutics Major Business
        2.1.3 United Therapeutics Prostacyclin Product and Services
        2.1.4 United Therapeutics Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 United Therapeutics Recent Developments/Updates
    2.2 Actelion (J & J)
        2.2.1 Actelion (J & J) Details
        2.2.2 Actelion (J & J) Major Business
        2.2.3 Actelion (J & J) Prostacyclin Product and Services
        2.2.4 Actelion (J & J) Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Actelion (J & J) Recent Developments/Updates
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Prostacyclin Product and Services
        2.3.4 GSK Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 GSK Recent Developments/Updates
    2.4 Teva
        2.4.1 Teva Details
        2.4.2 Teva Major Business
        2.4.3 Teva Prostacyclin Product and Services
        2.4.4 Teva Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Teva Recent Developments/Updates
    2.5 Toray
        2.5.1 Toray Details
        2.5.2 Toray Major Business
        2.5.3 Toray Prostacyclin Product and Services
        2.5.4 Toray Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Toray Recent Developments/Updates
    2.6 Tide Pharma
        2.6.1 Tide Pharma Details
        2.6.2 Tide Pharma Major Business
        2.6.3 Tide Pharma Prostacyclin Product and Services
        2.6.4 Tide Pharma Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Tide Pharma Recent Developments/Updates
    2.7 Bayer AG
        2.7.1 Bayer AG Details
        2.7.2 Bayer AG Major Business
        2.7.3 Bayer AG Prostacyclin Product and Services
        2.7.4 Bayer AG Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Bayer AG Recent Developments/Updates

3 Competitive Environment: Prostacyclin by Manufacturer
    3.1 Global Prostacyclin Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Prostacyclin Revenue by Manufacturer (2019-2024)
    3.3 Global Prostacyclin Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Prostacyclin by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Prostacyclin Manufacturer Market Share in 2023
        3.4.2 Top 6 Prostacyclin Manufacturer Market Share in 2023
    3.5 Prostacyclin Market: Overall Company Footprint Analysis
        3.5.1 Prostacyclin Market: Region Footprint
        3.5.2 Prostacyclin Market: Company Product Type Footprint
        3.5.3 Prostacyclin Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Prostacyclin Market Size by Region
        4.1.1 Global Prostacyclin Sales Quantity by Region (2019-2030)
        4.1.2 Global Prostacyclin Consumption Value by Region (2019-2030)
        4.1.3 Global Prostacyclin Average Price by Region (2019-2030)
    4.2 North America Prostacyclin Consumption Value (2019-2030)
    4.3 Europe Prostacyclin Consumption Value (2019-2030)
    4.4 Asia-Pacific Prostacyclin Consumption Value (2019-2030)
    4.5 South America Prostacyclin Consumption Value (2019-2030)
    4.6 Middle East and Africa Prostacyclin Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Prostacyclin Sales Quantity by Type (2019-2030)
    5.2 Global Prostacyclin Consumption Value by Type (2019-2030)
    5.3 Global Prostacyclin Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Prostacyclin Sales Quantity by Application (2019-2030)
    6.2 Global Prostacyclin Consumption Value by Application (2019-2030)
    6.3 Global Prostacyclin Average Price by Application (2019-2030)

7 North America
    7.1 North America Prostacyclin Sales Quantity by Type (2019-2030)
    7.2 North America Prostacyclin Sales Quantity by Application (2019-2030)
    7.3 North America Prostacyclin Market Size by Country
        7.3.1 North America Prostacyclin Sales Quantity by Country (2019-2030)
        7.3.2 North America Prostacyclin Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Prostacyclin Sales Quantity by Type (2019-2030)
    8.2 Europe Prostacyclin Sales Quantity by Application (2019-2030)
    8.3 Europe Prostacyclin Market Size by Country
        8.3.1 Europe Prostacyclin Sales Quantity by Country (2019-2030)
        8.3.2 Europe Prostacyclin Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Prostacyclin Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Prostacyclin Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Prostacyclin Market Size by Region
        9.3.1 Asia-Pacific Prostacyclin Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Prostacyclin Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Prostacyclin Sales Quantity by Type (2019-2030)
    10.2 South America Prostacyclin Sales Quantity by Application (2019-2030)
    10.3 South America Prostacyclin Market Size by Country
        10.3.1 South America Prostacyclin Sales Quantity by Country (2019-2030)
        10.3.2 South America Prostacyclin Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Prostacyclin Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Prostacyclin Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Prostacyclin Market Size by Country
        11.3.1 Middle East & Africa Prostacyclin Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Prostacyclin Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Prostacyclin Market Drivers
    12.2 Prostacyclin Market Restraints
    12.3 Prostacyclin Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Prostacyclin and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Prostacyclin
    13.3 Prostacyclin Production Process
    13.4 Prostacyclin Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Prostacyclin Typical Distributors
    14.3 Prostacyclin Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Prostacyclin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Prostacyclin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. United Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 4. United Therapeutics Major Business
    Table 5. United Therapeutics Prostacyclin Product and Services
    Table 6. United Therapeutics Prostacyclin Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. United Therapeutics Recent Developments/Updates
    Table 8. Actelion (J & J) Basic Information, Manufacturing Base and Competitors
    Table 9. Actelion (J & J) Major Business
    Table 10. Actelion (J & J) Prostacyclin Product and Services
    Table 11. Actelion (J & J) Prostacyclin Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Actelion (J & J) Recent Developments/Updates
    Table 13. GSK Basic Information, Manufacturing Base and Competitors
    Table 14. GSK Major Business
    Table 15. GSK Prostacyclin Product and Services
    Table 16. GSK Prostacyclin Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. GSK Recent Developments/Updates
    Table 18. Teva Basic Information, Manufacturing Base and Competitors
    Table 19. Teva Major Business
    Table 20. Teva Prostacyclin Product and Services
    Table 21. Teva Prostacyclin Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Teva Recent Developments/Updates
    Table 23. Toray Basic Information, Manufacturing Base and Competitors
    Table 24. Toray Major Business
    Table 25. Toray Prostacyclin Product and Services
    Table 26. Toray Prostacyclin Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Toray Recent Developments/Updates
    Table 28. Tide Pharma Basic Information, Manufacturing Base and Competitors
    Table 29. Tide Pharma Major Business
    Table 30. Tide Pharma Prostacyclin Product and Services
    Table 31. Tide Pharma Prostacyclin Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Tide Pharma Recent Developments/Updates
    Table 33. Bayer AG Basic Information, Manufacturing Base and Competitors
    Table 34. Bayer AG Major Business
    Table 35. Bayer AG Prostacyclin Product and Services
    Table 36. Bayer AG Prostacyclin Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Bayer AG Recent Developments/Updates
    Table 38. Global Prostacyclin Sales Quantity by Manufacturer (2019-2024) & (K Unit)
    Table 39. Global Prostacyclin Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 40. Global Prostacyclin Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 41. Market Position of Manufacturers in Prostacyclin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 42. Head Office and Prostacyclin Production Site of Key Manufacturer
    Table 43. Prostacyclin Market: Company Product Type Footprint
    Table 44. Prostacyclin Market: Company Product Application Footprint
    Table 45. Prostacyclin New Market Entrants and Barriers to Market Entry
    Table 46. Prostacyclin Mergers, Acquisition, Agreements, and Collaborations
    Table 47. Global Prostacyclin Sales Quantity by Region (2019-2024) & (K Unit)
    Table 48. Global Prostacyclin Sales Quantity by Region (2025-2030) & (K Unit)
    Table 49. Global Prostacyclin Consumption Value by Region (2019-2024) & (USD Million)
    Table 50. Global Prostacyclin Consumption Value by Region (2025-2030) & (USD Million)
    Table 51. Global Prostacyclin Average Price by Region (2019-2024) & (USD/Unit)
    Table 52. Global Prostacyclin Average Price by Region (2025-2030) & (USD/Unit)
    Table 53. Global Prostacyclin Sales Quantity by Type (2019-2024) & (K Unit)
    Table 54. Global Prostacyclin Sales Quantity by Type (2025-2030) & (K Unit)
    Table 55. Global Prostacyclin Consumption Value by Type (2019-2024) & (USD Million)
    Table 56. Global Prostacyclin Consumption Value by Type (2025-2030) & (USD Million)
    Table 57. Global Prostacyclin Average Price by Type (2019-2024) & (USD/Unit)
    Table 58. Global Prostacyclin Average Price by Type (2025-2030) & (USD/Unit)
    Table 59. Global Prostacyclin Sales Quantity by Application (2019-2024) & (K Unit)
    Table 60. Global Prostacyclin Sales Quantity by Application (2025-2030) & (K Unit)
    Table 61. Global Prostacyclin Consumption Value by Application (2019-2024) & (USD Million)
    Table 62. Global Prostacyclin Consumption Value by Application (2025-2030) & (USD Million)
    Table 63. Global Prostacyclin Average Price by Application (2019-2024) & (USD/Unit)
    Table 64. Global Prostacyclin Average Price by Application (2025-2030) & (USD/Unit)
    Table 65. North America Prostacyclin Sales Quantity by Type (2019-2024) & (K Unit)
    Table 66. North America Prostacyclin Sales Quantity by Type (2025-2030) & (K Unit)
    Table 67. North America Prostacyclin Sales Quantity by Application (2019-2024) & (K Unit)
    Table 68. North America Prostacyclin Sales Quantity by Application (2025-2030) & (K Unit)
    Table 69. North America Prostacyclin Sales Quantity by Country (2019-2024) & (K Unit)
    Table 70. North America Prostacyclin Sales Quantity by Country (2025-2030) & (K Unit)
    Table 71. North America Prostacyclin Consumption Value by Country (2019-2024) & (USD Million)
    Table 72. North America Prostacyclin Consumption Value by Country (2025-2030) & (USD Million)
    Table 73. Europe Prostacyclin Sales Quantity by Type (2019-2024) & (K Unit)
    Table 74. Europe Prostacyclin Sales Quantity by Type (2025-2030) & (K Unit)
    Table 75. Europe Prostacyclin Sales Quantity by Application (2019-2024) & (K Unit)
    Table 76. Europe Prostacyclin Sales Quantity by Application (2025-2030) & (K Unit)
    Table 77. Europe Prostacyclin Sales Quantity by Country (2019-2024) & (K Unit)
    Table 78. Europe Prostacyclin Sales Quantity by Country (2025-2030) & (K Unit)
    Table 79. Europe Prostacyclin Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Prostacyclin Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Prostacyclin Sales Quantity by Type (2019-2024) & (K Unit)
    Table 82. Asia-Pacific Prostacyclin Sales Quantity by Type (2025-2030) & (K Unit)
    Table 83. Asia-Pacific Prostacyclin Sales Quantity by Application (2019-2024) & (K Unit)
    Table 84. Asia-Pacific Prostacyclin Sales Quantity by Application (2025-2030) & (K Unit)
    Table 85. Asia-Pacific Prostacyclin Sales Quantity by Region (2019-2024) & (K Unit)
    Table 86. Asia-Pacific Prostacyclin Sales Quantity by Region (2025-2030) & (K Unit)
    Table 87. Asia-Pacific Prostacyclin Consumption Value by Region (2019-2024) & (USD Million)
    Table 88. Asia-Pacific Prostacyclin Consumption Value by Region (2025-2030) & (USD Million)
    Table 89. South America Prostacyclin Sales Quantity by Type (2019-2024) & (K Unit)
    Table 90. South America Prostacyclin Sales Quantity by Type (2025-2030) & (K Unit)
    Table 91. South America Prostacyclin Sales Quantity by Application (2019-2024) & (K Unit)
    Table 92. South America Prostacyclin Sales Quantity by Application (2025-2030) & (K Unit)
    Table 93. South America Prostacyclin Sales Quantity by Country (2019-2024) & (K Unit)
    Table 94. South America Prostacyclin Sales Quantity by Country (2025-2030) & (K Unit)
    Table 95. South America Prostacyclin Consumption Value by Country (2019-2024) & (USD Million)
    Table 96. South America Prostacyclin Consumption Value by Country (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Prostacyclin Sales Quantity by Type (2019-2024) & (K Unit)
    Table 98. Middle East & Africa Prostacyclin Sales Quantity by Type (2025-2030) & (K Unit)
    Table 99. Middle East & Africa Prostacyclin Sales Quantity by Application (2019-2024) & (K Unit)
    Table 100. Middle East & Africa Prostacyclin Sales Quantity by Application (2025-2030) & (K Unit)
    Table 101. Middle East & Africa Prostacyclin Sales Quantity by Region (2019-2024) & (K Unit)
    Table 102. Middle East & Africa Prostacyclin Sales Quantity by Region (2025-2030) & (K Unit)
    Table 103. Middle East & Africa Prostacyclin Consumption Value by Region (2019-2024) & (USD Million)
    Table 104. Middle East & Africa Prostacyclin Consumption Value by Region (2025-2030) & (USD Million)
    Table 105. Prostacyclin Raw Material
    Table 106. Key Manufacturers of Prostacyclin Raw Materials
    Table 107. Prostacyclin Typical Distributors
    Table 108. Prostacyclin Typical Customers
List of Figures
    Figure 1. Prostacyclin Picture
    Figure 2. Global Prostacyclin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Prostacyclin Consumption Value Market Share by Type in 2023
    Figure 4. Epoprostenol Sodium Examples
    Figure 5. Treprostinil Examples
    Figure 6. Iloprost Examples
    Figure 7. Beraprost Sodium Examples
    Figure 8. Global Prostacyclin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 9. Global Prostacyclin Consumption Value Market Share by Application in 2023
    Figure 10. For Injection Examples
    Figure 11. For Oral Examples
    Figure 12. For Inhalation Examples
    Figure 13. Global Prostacyclin Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Prostacyclin Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Prostacyclin Sales Quantity (2019-2030) & (K Unit)
    Figure 16. Global Prostacyclin Average Price (2019-2030) & (USD/Unit)
    Figure 17. Global Prostacyclin Sales Quantity Market Share by Manufacturer in 2023
    Figure 18. Global Prostacyclin Consumption Value Market Share by Manufacturer in 2023
    Figure 19. Producer Shipments of Prostacyclin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 20. Top 3 Prostacyclin Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Top 6 Prostacyclin Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Global Prostacyclin Sales Quantity Market Share by Region (2019-2030)
    Figure 23. Global Prostacyclin Consumption Value Market Share by Region (2019-2030)
    Figure 24. North America Prostacyclin Consumption Value (2019-2030) & (USD Million)
    Figure 25. Europe Prostacyclin Consumption Value (2019-2030) & (USD Million)
    Figure 26. Asia-Pacific Prostacyclin Consumption Value (2019-2030) & (USD Million)
    Figure 27. South America Prostacyclin Consumption Value (2019-2030) & (USD Million)
    Figure 28. Middle East & Africa Prostacyclin Consumption Value (2019-2030) & (USD Million)
    Figure 29. Global Prostacyclin Sales Quantity Market Share by Type (2019-2030)
    Figure 30. Global Prostacyclin Consumption Value Market Share by Type (2019-2030)
    Figure 31. Global Prostacyclin Average Price by Type (2019-2030) & (USD/Unit)
    Figure 32. Global Prostacyclin Sales Quantity Market Share by Application (2019-2030)
    Figure 33. Global Prostacyclin Consumption Value Market Share by Application (2019-2030)
    Figure 34. Global Prostacyclin Average Price by Application (2019-2030) & (USD/Unit)
    Figure 35. North America Prostacyclin Sales Quantity Market Share by Type (2019-2030)
    Figure 36. North America Prostacyclin Sales Quantity Market Share by Application (2019-2030)
    Figure 37. North America Prostacyclin Sales Quantity Market Share by Country (2019-2030)
    Figure 38. North America Prostacyclin Consumption Value Market Share by Country (2019-2030)
    Figure 39. United States Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Canada Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Mexico Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Europe Prostacyclin Sales Quantity Market Share by Type (2019-2030)
    Figure 43. Europe Prostacyclin Sales Quantity Market Share by Application (2019-2030)
    Figure 44. Europe Prostacyclin Sales Quantity Market Share by Country (2019-2030)
    Figure 45. Europe Prostacyclin Consumption Value Market Share by Country (2019-2030)
    Figure 46. Germany Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. France Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. United Kingdom Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Russia Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Italy Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Asia-Pacific Prostacyclin Sales Quantity Market Share by Type (2019-2030)
    Figure 52. Asia-Pacific Prostacyclin Sales Quantity Market Share by Application (2019-2030)
    Figure 53. Asia-Pacific Prostacyclin Sales Quantity Market Share by Region (2019-2030)
    Figure 54. Asia-Pacific Prostacyclin Consumption Value Market Share by Region (2019-2030)
    Figure 55. China Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Japan Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Korea Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. India Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Southeast Asia Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Australia Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. South America Prostacyclin Sales Quantity Market Share by Type (2019-2030)
    Figure 62. South America Prostacyclin Sales Quantity Market Share by Application (2019-2030)
    Figure 63. South America Prostacyclin Sales Quantity Market Share by Country (2019-2030)
    Figure 64. South America Prostacyclin Consumption Value Market Share by Country (2019-2030)
    Figure 65. Brazil Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Argentina Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Middle East & Africa Prostacyclin Sales Quantity Market Share by Type (2019-2030)
    Figure 68. Middle East & Africa Prostacyclin Sales Quantity Market Share by Application (2019-2030)
    Figure 69. Middle East & Africa Prostacyclin Sales Quantity Market Share by Region (2019-2030)
    Figure 70. Middle East & Africa Prostacyclin Consumption Value Market Share by Region (2019-2030)
    Figure 71. Turkey Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Egypt Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Saudi Arabia Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. South Africa Prostacyclin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Prostacyclin Market Drivers
    Figure 76. Prostacyclin Market Restraints
    Figure 77. Prostacyclin Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Prostacyclin in 2023
    Figure 80. Manufacturing Process Analysis of Prostacyclin
    Figure 81. Prostacyclin Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG